AURA - Company ID 0001501796
Aura Biosciences, Inc. trades as AURA. This page tracks Aura Biosciences, Inc. through 346 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-19 |
| Employee stock plan | S-8 | 2026-05-19 |
| SCHEDULE 13G | - | 2026-05-12 |
| Quarterly report | 10-Q | 2026-05-11 |
| Major company event | 8-K | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| SCHEDULE 13D/A | - | 2026-05-11 |
| New insider ownership | 3 | 2026-05-07 |
The largest companies sharing Aura Biosciences, Inc.'s SEC industry classification (biological products, (no diagnostic substances)).
In its latest fiscal year Aura Biosciences, Inc. reported a net loss of $106.19M.